Altered Chemokine Receptor Sensitivity in FVBN202 Rat neu Transgenic Mice
- 1 February 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 77 (3) , 225-232
- https://doi.org/10.1023/a:1021853202515
Abstract
We report here that breast cancer cells from spontaneous tumors that arise in rat neutransgenic mice produce several chemokines capable of acting upon cells of the immune system. Moreover, mice...Keywords
This publication has 16 references indexed in Scilit:
- Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cellsNature Medicine, 2001
- CXCL10 (IFN-γ-Inducible Protein-10) Control of Encephalitogenic CD4+ T Cell Accumulation in the Central Nervous System During Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2001
- Chemokine Receptor Desensitization in Tumor-Bearing MiceCellular Immunology, 2001
- Local Blockade of Allergic Airway Hyperreactivity and Inflammation by the Poxvirus-Derived Pan-CC-Chemokine Inhibitor vCCIThe Journal of Immunology, 2000
- RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregationInternational Immunology, 2000
- MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cellsImmunology Letters, 1999
- The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude miceBritish Journal of Cancer, 1999
- Activation of Dual T Cell Signaling Pathways by the Chemokine RANTESScience, 1995
- The role of chemokines in Schistosoma mansoni granuloma formationParasitology Today, 1994
- Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.Proceedings of the National Academy of Sciences, 1992